The GIP receptor appears to enhance the appetite-suppressing effects of GLP-1 signaling and may have additional benefits for fat metabolism
This innovative medication has shown promising results for managing diabetes and obesity
Wegovy injection site reactions Some people may experience skin irritation at the injection site, including rash, itchiness, or redness
But the next generationled by retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptorsis showing even more profound benefits
The most prevalent risk factor for colon ischemia in one study was the use of drugs with a side effect of constipation [5]
This test, available as a $99 add-on after your first month of semaglutide treatment, reveals your genetic predisposition to weight loss and helps optimize your personalized dosing protocol for maximum fat loss and muscle preservation